TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive In Brief: Boutwell Declines Nomination to New NCAB Term; Rowley Again Urges Appointment Of Scientists January 20, 1984
TCL Archive Oregon Center Launching $1 Billion Program To Identify Lethal Cancers Before They Kill May 9, 2014
TCL Archive In Brief: Carcinogenesis Task Force to Wrap Up Review In Four-Six Weeks; UCLA Groundbreaking Set October 28, 1977
